<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02529085</url>
  </required_header>
  <id_info>
    <org_study_id>12 359 03</org_study_id>
    <nct_id>NCT02529085</nct_id>
  </id_info>
  <brief_title>PWS European Blood Bank for Infants and Controls From 0 to 48 Months</brief_title>
  <official_title>Study of Early Endocrine Profile in Infants With Prader-Willi Syndrome (PWS) in Order to Unravel the Switch From Early Feeding Difficulties to Obesity and Hyperphagia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Society for Paediatric Endocrinology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present project aims to determine the underlying mechanisms for the switch from failure
      to thrive to excessive weight gain and hyperphagia with impaired satiety in PWS. The primary
      objective is to describe the evolution of circulating hormones involved in feeding and
      appetite regulation during the 4 first years of life. The secondary objective is to make this
      blood bank available for other research projects and particularly the investigation of
      hormones involved in hypogonadism.

      Over the last ten years, the age at diagnosis in PWS has fallen significantly and the
      majority of cases is now diagnosed during the 1st trimester of life giving the possibility to
      collect precise clinical data and serum samples at early stages. The investigators of the
      project are involved in the care of patients with PWS and have a devoted clinic and an
      organized network in their country through clinical networks or patient associations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators propose to perform a prospective multicentric study, both longitudinal
      (duration 30 months) and cross-sectional with implementation of a blood bank in link with a
      multicenter database including clinical data on birth, auxology, endocrine functions and
      feeding behaviour. The cohort will include 200 infants from 3 to 48 months with PWS and 200
      controls matched on age recruited in the 6 participating countries. The investigators make
      the assumption that 3 blood sampling will be necessary during the first year and 6 monthly
      sampling thereafter. For measuring hormones and neuropeptides (ghrelin, insulin, leptin,
      pancreatic polypeptide, oxytocin, cortisol, melatonin, orexin A, GLP-1 and PYY) involved in
      feeding and appetite regulation the investigators will use primarily multiplex microplates
      technics requiring 50-200µl of sample. Intragroup and intergroup comparisons will be
      performed in order to describe the evolution of each hormone with time and to compare data
      obtained in the PWS group with those obtained in the control group.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Levels of hormones and neuropeptides</measure>
    <time_frame>42 months</time_frame>
    <description>Measure of hormones and neuropeptides (ghrelin, insulin, leptin, pancreatic polypeptide, oxytocin, melatonin, orexins) involved in feeding and appetite regulation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation between hormones and neuropeptides levels</measure>
    <time_frame>42 months</time_frame>
    <description>study the correlation between ghrelin, insulin, leptin, pancreatic polypeptide, oxytocin, melatonin, orexins</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Prader-Willi Syndrome</condition>
  <arm_group>
    <arm_group_label>Infants with PWS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blood samples for the bank in link with a multicenter database including clinical data on birth, auxology, endocrine functions and feeding behaviour</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Blood samples for the bank in children hospitalized for a planned surgery for malformation, orthopaedic or visceral surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood samples</intervention_name>
    <description>blood samples for the bank</description>
    <arm_group_label>Infants with PWS</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (PWS infants cohort)

          -  Genetic diagnosis of Prader-Willi syndrome

        Exclusion Criteria (PWS infants cohort)

        Inclusion Criteria (control group)

          -  children hospitalized for a planned surgery for malformation, orthopaedic or visceral
             surgery

        Exclusion Criteria (control group)

          -  children with endocrine disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maithe TAUBER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maithe TAUBER, MD</last_name>
    <phone>534558551</phone>
    <phone_ext>33</phone_ext>
    <email>tauber.mt@chu-toulouse.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Catherine MOLINAS.</last_name>
    <phone>534558698</phone>
    <phone_ext>33</phone_ext>
    <email>molinas.c@chu-toulouse.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Unité d'Endocrinologie Pédiatrique / Université Catholique de Louvain</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Véronique. BEAULOYE, MD</last_name>
      <email>veronique.beauloye@uclouvain.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Pediatrics / Division of Endocrinology</name>
      <address>
        <city>Toulouse</city>
        <state>Haute-Garonne</state>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maithe TAUBER, MD</last_name>
      <phone>534558551</phone>
      <phone_ext>33</phone_ext>
      <email>tauber.mt@chu-toulouse.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Endocrinology / University Children's Hospital</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Berthold. HAUFFA, MD</last_name>
      <email>berthold.hauffa@uni-essen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Pediatrics / Division of Endocrinology / Erasmus University Medical Center / Sophia Children's Hospital Rotterdam</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015 GJ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anita. HOKKEN-KOELAGA, MD</last_name>
      <email>a.hokken@erasmusmc.nl</email>
    </contact>
    <contact_backup>
      <last_name>Renske KUPPENS, MD</last_name>
      <email>r.kuppens@kindengroei.nl</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricard NERGARDH, MD</last_name>
      <email>ricard.nergardh@ki.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Metabolic &amp; Molecular Imaging Group / MRC Clinical Sciences Centre / Imperial College London / Hammersmith Hospital</name>
      <address>
        <city>London</city>
        <zip>W12 0NN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Cadoudal T, Buléon M, Sengenès C, Diene G, Desneulin F, Molinas C, Eddiry S, Conte-Auriol F, Daviaud D, Martin PG, Bouloumié A, Salles JP, Tauber M, Valet P. Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment. Int J Obes (Lond). 2014 Sep;38(9):1234-40. doi: 10.1038/ijo.2014.3. Epub 2014 Jan 10.</citation>
    <PMID>24406482</PMID>
  </reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2015</study_first_submitted>
  <study_first_submitted_qc>August 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2015</study_first_posted>
  <last_update_submitted>May 6, 2016</last_update_submitted>
  <last_update_submitted_qc>May 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Prader-Willi Syndrome</mesh_term>
    <mesh_term>Hyperphagia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

